Health-related quality-of-life tools in heart failure

References

• Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine, Fifth Edition. Braunwald E (Ed.), Saunders, PA, USA (1997).
   Google Scholar
• Davies M, Hobbs F, Davis R et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 358(9280), 439–444 (2001).
   PubMed Web of Science ®Google Scholar
• Hobbs FD. Unmet need for diagnosis of heart failure: the view from primary care. Heart 88(Suppl. 2), 9–11 (2002).
   Web of Science ®Google Scholar
• McDonagh TA, Morrison CE, Lawrence A et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350(9081), 829–833 (1997).
   PubMed Web of Science ®Google Scholar
• Cowie MR. BNP: soon to become a routine measure in the care of patients with heart failure? Heart 83(6), 617–618 (2000).
   PubMed Web of Science ®Google Scholar
• O Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J. Heart Lung Transplant 13(4), S107–S112 (1994).
   PubMed Web of Science ®Google Scholar
• Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J. Am. Coll. Cardiol. 26(7), 1565–1574 (1995).
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol. 33(7), 1948–1955 (1999).
   PubMed Web of Science ®Google Scholar
• Kitzman DW, Gardin JM, Gottdiener JS et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am. J. Cardiol. 87(4), 413–419 (2001).
   PubMed Web of Science ®Google Scholar
• Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from ‘diastolic heart failure’ or from misdiagnosis? A prospective descriptive study. Br. Med. J. 321(7255), 215–218 (2000).
   PubMed Web of Science ®Google Scholar
• Banerjee P, BanerjeeT, Khand A, Clark AL, Cleland JG. Diastolic heart failure:neglected or misdiagnosed? J. Am. Coll. Cardiol. 39, 138–141 (2002).
   PubMed Web of Science ®Google Scholar
• Cohn JN. Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure Trial. Cardiology 91(Suppl. 1), 19–22 (1999).
   PubMed Web of Science ®Google Scholar
• Alla F, Briancon S, Guillemin F et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur. J. Heart Fail. 4(3), 337–343 (2002).
   PubMed Web of Science ®Google Scholar
• Calvert MJ, Freemantle N, Cleland JG. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur. J. Heart Fail. 7(2), 243–251 (2005).
   PubMed Web of Science ®Google Scholar
• Oldridge N, Perkins A, Hodes Z. Comparison of three heart disease specific health-related quality of life instruments. Monaldi Arch. Chest Dis. 58(1), 10–18 (2002).
   PubMedGoogle Scholar
• Streiner D, Norman G. Health Measurement Scales: a Practical Guide to Their Development and Use, Second Edition. Oxford University Press, Oxford, UK (1995).
   Google Scholar
• Jaarsma T, Stromberg A, Martensson J, Dracup K. Development and testing of the European Heart Failure Self-Care Behaviour Scale. Eur. J. Heart Fail. 5(3), 363–370 (2003).
   PubMed Web of Science ®Google Scholar
• Arena R, Humphrey R, Peberdy MA. Using the Duke Activity Status Index in heart failure. J. Cardiopulm. Rehabil. 22, 93–93 (2002).
   PubMedGoogle Scholar
• Steinhauser KE, Bosworth HB, Clipp EC et al. Initial assessment of a new instrument to measure quality of life at the end of life. J. Palliat. Med. 5(6), 829–841 (2002).
   PubMedGoogle Scholar
• Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am. Heart J. 124(4), 1017–1025 (1992).
   PubMed Web of Science ®Google Scholar
• Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am. J. Cardiol. 71(12), 1106–1107 (1993).
   PubMed Web of Science ®Google Scholar
• Middel B, Bouma J, de Jongste M et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHFQ-Q). Clin. Rehabil. 15(5), 489–500 (2001).
   PubMed Web of Science ®Google Scholar
• Bennett SJ, Oldridge NB, Eckert GJ et al. Discriminant properties of commonly used quality of life measures in heart failure. Qual. Life Res. 11(4), 349–359 (2002).
   PubMed Web of Science ®Google Scholar
• Bennett SJ, Oldridge NB, Eckert GJ et al. Comparison of quality of life measures in heart failure. Nurs. Res. 52(4), 207–216 (2003).
   PubMed Web of Science ®Google Scholar
• Riegel B, Moser DK, Glaser D et al. The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurs. Res. 51(4), 209–218 (2002).
   PubMed Web of Science ®Google Scholar
• Hou N, Chui MA, Eckert GJ, Oldridge NB, Murray MD, Bennett SJ. Relationship of age and sex to health-related quality of life in patients with heart failure. Am. J. Crit. Care 13(2), 153–161 (2004).
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Nogradi S, Halcrow S, Singer J, Sullivan MJ, Fallen EL. Development and testing of a new measure of health status for clinical trials in heart failure. J. Gen. Intern. Med. 4(2), 101–107 (1989).
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Sullivan CM, Fallen EL. A controlled trial of digoxin in congestive heart failure. Am. J. Cardiol. 61, 371–375 (1988).
   PubMed Web of Science ®Google Scholar
• Wolinsky FD, Wyrwich KW, Nienaber NA, Tierney WM. Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Eval. Health Prof. 21(2), 216–243 (1998).
   PubMed Web of Science ®Google Scholar
• Guyatt GH. Measurement of health-related quality of life in heart failure. J. Am. Coll. Cardiol. 22(4 Suppl. A), 185A–191A (1993).
   PubMed Web of Science ®Google Scholar
• Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J. Am. Coll. Cardiol. 35(5), 1245–1255 (2000).
   PubMed Web of Science ®Google Scholar
• Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation 110(5), 546–551 (2004).
   PubMed Web of Science ®Google Scholar
• Hauptman PJ, Masoudi FA, Weintraub WS, Pina I, Jones PG, Spertus JA. Variability in the clinical status of patients with advanced heart failure. J. Card. Fail. 10(5), 397–402 (2004).
   PubMed Web of Science ®Google Scholar
• Clark DO, Tu W, Weiner M, Murray MD. Correlates of health-related quality of life among lower-income, urban adults with congestive heart failure. Heart Lung 32(6), 391–401 (2003).
   PubMed Web of Science ®Google Scholar
• Wiklund I, Lindvall K, Swedberg K, Zupkis RV. Self-assessment of quality of life in severe heart failure. An instrument for clinical use. Scand. J. Psychol. 28(3), 220–225 (1987).
   PubMed Web of Science ®Google Scholar